Zacks Investment Research Upgrades Novus Therapeutics (NASDAQ:NVUS) to “Buy” - TechNewsObserver

Zacks Investment Research Upgrades Novus Therapeutics (NASDAQ:NVUS) to “Buy”  TechNewsObserver

Zacks Investment Research upgraded shares of Novus Therapeutics (NASDAQ:NVUS) from a hold rating to a buy rating in a report published on Friday morning, ...



Comments

Popular posts from this blog

Uveitis Eye Inflammation Causes, Symptoms & Treatment

Robert Zakar gives back to community

Goopy Eyes: Causes and Treatment